NuGen Medical Devices Inc.

Equities

NGMD

CA67054F1009

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. Other stock markets 15:00:52 2024-06-28 EDT			5-day change	1st Jan Change
0.095 ^CAD	-5.00%		-20.83%	-20.83%

05-30	NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-30	NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

April 27, 2023 at 01:37 pm

(via NewsDirect)

NuGen Medical Devices executive chairman Tony Di Benedetto joined Steve Darling from Proactive to provide details about the company that is developing the next generation of needle-free technologies for both humans and animals.

Di Benedetto shares with Proactive more about the technology behind products InsuJet and PetJet and also about an assessment and feasibility study in the Netherlands of InsuJet for Semaglutide or its more widely known name Ozempic.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

Latest news about NuGen Medical Devices Inc.

NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
NuGen Medical Devices Inc. Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru	01-19	CI
NuGen Medical Devices Inc. Signs 5-Year Distribution Agreement for InsuJet with Verrue Consulting Group in Belgium	12-19	CI
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet with Advance Medical Life	12-14	CI
NuGen Medical Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
NuGen Medical Devices Inc. Reports Distribution Agreement with Science-Link Trading SAPI de CV	11-13	CI
Nugen Medical Devices Inc. Announces the Official Launch on Shopify of Its Diabetic's Lifestyle Subscription Business	11-07	CI
NuGen Medical Devices Inc. Announces Chief Executive Officer Changes	23-10-12	CI
NuGen Medical Devices Inc. Presents New Data from Preliminary Trial That Semaglutide (Ozempic ) Is Chemically Stable After It Is Administered Through Nugen 's InsuJet Needle-Free Injection Device	23-10-10	CI
NuGen Medical Devices Inc. Completes Delivery and First Sale of 500 InsuJet Devices and Consumables in Romania	23-09-20	CI
NuGen Medical Devices Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
NuGen Medical Devices Inc. Enters into Distribution Agreement with Sol-Millennium Medical Inc	23-07-24	CI
NuGen Medical Devices Inc. Announces Executive Changes	23-06-23	CI
Nugen Medical Devices Inc. Announces InsuJetTM Now Registered for Supply Through Reliance Medical Group	23-06-09	CI
NuGen Medical Devices Inc. Receives its First Bulk Purchase Order from Science-Link Trading SAPI de CV for the Mexican Market for 500 Units of the Company's Needly-Free InsuJet InsuJet InsuJet™? Injection Device	23-06-02	CI
NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
NuGen Medical Devices Up 2.3% After Reporting Closing of Non-Brokered Private Placement of Units	23-05-18	MT
NuGen Medical Devices Inc. announced that it has received CAD 0.45 million in funding	23-05-17	CI
NuGen Medical Devices Inc. Auditor Raises 'Going Concern' Doubt	23-04-30	CI
NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
NuGen Medical Devices Inc. announced that it has received CAD 4 million in funding	23-04-24	CI
NuGen Medical Devices Inc. Engages Basic Pharma Technologies to Perform an Assessment and Feasibility Study	23-04-10	CI
NuGen Medical Devices Inc. announced that it expects to receive CAD 3.6 million in funding	23-03-30	CI
NuGen Medical Devices Inc. Engages with Sol-Millennium	23-03-27	CI

Chart NuGen Medical Devices Inc.

Duration

Period

More charts

Company Profile

NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-19 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NUGEN MEDICAL DEVICES INC.	-20.83%	15.02M
ABBOTT LABORATORIES	-6.24%	181B
MEDTRONIC PLC	-6.39%	101B
BECTON, DICKINSON AND COMPANY	-5.97%	67.54B
DEXCOM, INC.	-9.61%	45.09B
CENCORA, INC.	+8.84%	44.37B
HOYA CORPORATION	+8.00%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.69%	29.85B
TERUMO CORPORATION	+10.34%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-7.83%	23.99B

Other Medical Equipment, Supplies & Distribution